Skip to Navigation
Skip to Content
 
Home> The International Journal of Neuropsychopharmacology> Top 10 Most-Cited Articles

 

Log In

Browse Journals

Special Sales

Cambridge Journals Digital Archive

Click here for details about our archive digitisation project. more details

2009 Journals Catalogue

Click here to download a PDF of our latest catalogue; a comprehensive guide to all of our journals. more details

CJO Now Includes:

568,935 articles from 321 leading journals.

Customize Your Search Toolbar

Top 10 Most-Cited Articles


These are the top 10 most-cited articles for this title. Most-cited rankings are updated on a monthly basis and provided by CrossRef.

  • Subscription Access
  • Free Access
  • Trial Access
  • Full Text HTML as well as PDF Articles Available
  • Note: Abstract, PDF and HTML open in a new window
  Article Description Save / Export / View citation Add to Basket
  Select all
 

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

Siegfried Kasper, Mark N. Lerman, Robert D. McQuade, Anutosh Saha, William H. Carson, Mirza Ali, Donald Archibald, Gary Ingenito, Ronald Marcus and Teresa Pigott

The International Journal of Neuropsychopharmacology, Volume 6, Issue 04, Dec 2003, pp 325-337
doi: 10.1017/S1461145703003651 (About doi), Published online by Cambridge University Press 08 Dec 2003
 

Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis

Tal Burt, Sarah H. Lisanby and Harold A. Sackeim

The International Journal of Neuropsychopharmacology, Volume 5, Issue 01, Mar 2002, pp 73-103
doi: 10.1017/S1461145702002791 (About doi), Published online by Cambridge University Press 28 Mar 2002
Full Text HTML as well as PDF Articles Available

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

Neil D. Woodward, Scot E. Purdon, Herbert Y. Meltzer and David H. Zald

The International Journal of Neuropsychopharmacology, Volume 8, Issue 03, Sep 2005, pp 457-472
doi: 10.1017/S146114570500516X (About doi), Published online by Cambridge University Press 23 Mar 2005
 

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease

Steven G. Potkin, Ravi Anand, Kirsten Fleming, Gustavo Alva, David Keator, Danilo Carreon, John Messina, Joseph C. Wu, Richard Hartman and James H. Fallon

The International Journal of Neuropsychopharmacology, Volume 4, Issue 03, Sep 2001, pp 223-230
doi: 10.1017/S1461145701002528 (About doi), Published online by Cambridge University Press 25 Sep 2001
Full Text HTML as well as PDF Articles Available

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

Joseph Biederman, Thomas Spencer and Timothy Wilens

The International Journal of Neuropsychopharmacology, Volume 7, Issue 01, Mar 2004, pp 77-97
doi: 10.1017/S1461145703003973 (About doi), Published online by Cambridge University Press 05 Feb 2004
Full Text HTML as well as PDF Articles Available

Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women

Katharina Domschke, Christine M. Freitag, Gregor Kuhlenbäumer, Anja Schirmacher, Philipp Sand, Peter Nyhuis, Christian Jacob, Jürgen Fritze, Petra Franke, Marcella Rietschel, Henk S. Garritsen, Rolf Fimmers, Markus M. Nöthen, Klaus-Peter Lesch, Florian Stögbauer and Jürgen Deckert

The International Journal of Neuropsychopharmacology, Volume 7, Issue 02, Jun 2004, pp 183-188
doi: 10.1017/S146114570400416X (About doi), Published online by Cambridge University Press 04 May 2004
 

Long-term symptomatic status of bipolar I vs. bipolar II disorders

Lewis L. Judd, Pamela J. Schettler, Hagop S. Akiskal, Jack Maser, William Coryell, David Solomon, Jean Endicott and Martin Keller

The International Journal of Neuropsychopharmacology, Volume 6, Issue 02, Jun 2003, pp 127-137
doi: 10.1017/S1461145703003341 (About doi), Published online by Cambridge University Press 09 Jun 2003
Full Text HTML as well as PDF Articles Available

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

Todd D. Gould, Haim Einat, Ratan Bhat and Husseini K. Manji

The International Journal of Neuropsychopharmacology, Volume 7, Issue 04, Dec 2004, pp 387-390
doi: 10.1017/S1461145704004535 (About doi), Published online by Cambridge University Press 08 Nov 2004
 

Do we still believe in the dopamine hypothesis? New data bring new evidence

Anissa Abi-Dargham

The International Journal of Neuropsychopharmacology, Volume 7, Supplement S1, Mar 2004, pp S1-S5
doi: 10.1017/S1461145704004110 (About doi), Published online by Cambridge University Press 19 Feb 2004
Full Text HTML as well as PDF Articles Available

Association of the C(–1019)G 5-HT1A functional promoter polymorphism with antidepressant response

Sylvie Lemonde, Lisheng Du, David Bakish, Pavel Hrdina and Paul R. Albert

The International Journal of Neuropsychopharmacology, Volume 7, Issue 04, Dec 2004, pp 501-506
doi: 10.1017/S1461145704004699 (About doi), Published online by Cambridge University Press 08 Nov 2004
  Select all
  Article Description Save / Export / View citation Add to Basket

Back to Journal Homepage
Cambridge University Press